Rhythm Biosciences Ltd has released a press release.
ColoSTAT Kit Validation Completion and NATA Submission
Filed with ASX ·
6ix hasn’t read this filing yet.
Rhythm Biosciences Limited on 6ix
Earlier from Rhythm Biosciences
- Placement Prospectus
- Share Placement to Raise Up To $3.75 million
- Placement Issue Investor Presentation
- Response to ASX Price Query
- ColoSTAT Kits Deliver Breakthrough Results
Later from Rhythm Biosciences
- Strategic partnership with Know Your Lemons Foundation
- Appendix 4E
- Appendix 4C and Market Update
- Rhythm Initiates Commercialisation of ColoSTAT
- datma and Rhythm Biosciences Announce Collaboration to Apply Federated Real-World Data to Genomic Diagnostic Development
Follow Rhythm Biosciences into a list and get an email when it puts out news.
Follow Rhythm Biosciences